For additional information contact:
- ACS Helpdesk
phone: (1-800)-227-9919 or (202)-872-HELP / 4357
- Management contact, Sarah Tegen
Q: What are the ACS Open Access Initiatives?
ACS Central Science
- ACS Central Science is the American Chemical Society’s first completely open access journal. It will be highly selective and rigorously peer-reviewed and will publish approximately 100-200 articles a year. It will be the first such chemistry-related journal published by a major global scientific society in an open access model.
- All peer-reviewed articles accepted by ACS Central Science will be original to that publication.
- Peer-reviewed articles published in ACS Central Science will be made freely available online immediately upon publication and without article publishing charges to authors.
- The journal is intended to complement the Society’s portfolio of subscription-based journals, for those authors who seek to publish in an open access forum of distinction.
ACS Editors’ Choice
- ACS Editors’ Choice is a new service that selects, features, and makes openly available one new article a day, from the breadth of ACS’s 44 peer-reviewed journals. These articles will remain open for all to access and read.
- It is not a separate journal; it is an author and reader service designed to maximize readership and awareness and broadly promote the range of work published by ACS.
- This service started January 2014. Any peer-reviewed articles published in ACS journals qualify for consideration by ACS Editors; authors do not need to specially apply for this program.
ACS Author Rewards
- ACS Author Rewards is a program designed to encourage researchers to participate in open access publishing models in ACS journals during a time when funder and institutional requirements are still in flux and vary widely from country to country or institution to institution.
- Each peer-reviewed article published in any ACS journal during 2014 qualifies the published corresponding author for ACS Author Rewards article credits. For maximum convenience, ACS offers published corresponding authors 2 credits that can be exchanged for up to $750 each for ACS AuthorChoice services–a total value of $1,500 per article published in 2014. Vouchers may be redeemed from January 1, 2015 through Dececember 31, 2017.
- For a fee, ACS AuthorChoice allows authors the ability to sponsor their work to be made openly available to all readers without subscription access. It has been available since 2006. Beginning in 2014, this program has new options, fees, and discounts. Full details can be found on www.acsopenaccess.org.
- ACS AuthorChoice has been expanded to allow authors to choose between immediate availability (ACS AuthorChoice) or availability 12 months after publication of the version of record (ACSAuthorChoice+12), depending on their preference and funder requirements. ACS AuthorChoice options provide progressive discounts if the corresponding author is a member of the American Chemical Society and/or is affiliated with an institution that subscribes to the ACS All Publications package. In addition, authors may also elect a Creative Commons Attribution (CC-BY) or a Creative Commons Attribution Noncommercial No Derivative Works (CC-BY-NC-ND) license.
Q: How do I find out more information on ACS Open Access programs and products?
A: There are several options:
- Go to www.acsopenaccess.org we will keep that site up to date and expand information as it becomes available. Sign up for email alerts on various aspects of the ACS publishing program and services on www.acsopenaccess.org.
- Go to the ACS Author and Reviewer Center for information regarding ACS license and publishing options. Similarly ACS will update information on these programs specific to the library community on their library focused website, ACS InfoCentral.
- ACS plans to offer a series of webinars to answer questions from the wide range of stakeholders interested in this program. Information on these events will be released on the ACS Publications websites as they are scheduled.
- If you are an author, you can pose specific questions with the ACS Help desk by phone, (1-800)-227-9919 or (202)-872-HELP / 4357; email firstname.lastname@example.org
- If you are librarian, contact Sara Rouhi, ACS manager, Library Relations
- If you are a member of the press, contact the ACS Office of Public Affairs, Falgren Mortine or Janelle Huelsman.
General Q&A about the ACS Open Access Initiatives
Q: Why is ACS introducing these initiatives?
A: These initiatives were designed to help ACS authors publish their work open access and meet existing, new, and emerging public access requirements from their funders and institutions. (ACS AuthorChoice is fully compliant with current NIH and Wellcome Trust accessibility guidelines.)
Q: With the addition of the ACS Open Access initiatives, will ACS Articles on Request remain the same?
A: Yes, ACS Articles on Request remains the same.
Q: What is ACS Articles on Request?
A: With ACS Articles on Request, corresponding authors are emailed a link that provides for up to 50 free e-prints of the final published article during the first 12 months following online publication. The link can be posted on the author’s website or sent via e-mail from the author to interested colleagues. The link provides access to both the full text HTML and PDF. Those users who already have subscription access privileges obtain seamless IP-based access, and their access does not count against the 50 free e-prints allowance. ACS Articles on Request allows an author’s article to be accessed without restriction 12 months after web publication.
Q: Will ACS articles published under an ACS AuthorChoice open access license be easily identified on the ACS Publications platform?
Q: What licensing rights will apply for ACS Central Science and ACS Editors’ Choice?
A: Authors will sign ACS’s standard Journal Publishing Agreement when their papers are submitted. Once their article has been selected for ACS Central Science or ACS Editors’ Choice they will be extended a complimentary ACS AuthorChoice license.
Q: What is ACS Certified Deposit?
A: ACS AuthorChoice authors benefit from the security and convenience of ACS Certified Deposit. ACS manages the required deposit of the final published article to repositories as directed by the author and maintains records to certify compliance.
- Note: Authors can only participate in the ACS Certified Deposit program if they select ACS AuthorChoice. ACS Central Science authors and ACS Editors’ Choice authors are part of ACS AuthorChoice and are automatically extended ACS Certified Deposit privileges.
Q: What is a Creative Commons license? What is the difference between Creative Commons license flavors?
A: Creative Commons is a nonprofit organization that offers and promotes several standardized licenses that define which rights copyright holders reserve and which they waive. They are typically referred to by a series of alphabet paired codes, such CC-BY, that act as a widely understood shorthand for the rights restrictions that license manages. Typically these revolve around the rights to reuse, modify, and/or monetize the original work, with or without attribution. For example, the CC-BY license now required by several UK-based funders permits wide reuse, including modification, derivative works, and commercial reuse. The CC-BY-ND-NC license does not allow third parties to create derivative works such as translations and only permits other types of use for noncommercial purposes. For more details on the Creative Commons license, visit the Creative Commons website.
Q: Does ACS Open Access Initiatives include content from the ACS Symposium Series?
A: At this time, our policies and programs are focused on journal content, and do not extend to book chapters. As we continue to develop our open access programs and research opportunities for books, we welcome input from authors to ensure we are meeting their needs.
Q: What is ACS Central Science?
A: ACS Central Science will be the American Chemical Society’s first completely open access journal and the first highly selective, society-published, pure open access journal to cover the breadth of chemistry and its interfaces with research in the natural and physical sciences. It will be led by a renowned scientist and an international editorial board, with peer review overseen by active research scientists representative of the journal’s planned disciplinary and geographic diversity. All articles will be made freely available online immediately upon publication and without article publishing charges levied on authors. In addition, the journal will seek to incorporate expanded analysis and commentary on groundbreaking research published in the journal as well as global trends in scientific research and development.
Q: What will be the scope of this new journal?
A: This peer-reviewed journal will publish exceptional papers across the broad spectrum of the chemical sciences, including chemistry and chemical engineering, life sciences and biomedicine, physics and materials science, and computational science and engineering. A more detailed statement of the journal’s scope will be available in 2014, once an Editor-in-Chief is selected and Editorial Board is appointed.
Q: How will ACS Central Science be different from JACS?
A: ACS Central Science will be a highly selective journal, publishing about 100-200 papers/year deemed by editors and reviewers to be of exceptional interest and importance.
- The scope of ACS Central Science will be fully established by the founding Editor-in-Chief. ACS Central Science is conceived to be a multidisciplinary journal attracting the best original research across a wide array of disciplines. This will include traditional areas of chemistry including organic, inorganic, and physical chemistry as well as more applied areas of chemistry, including computational and theoretical chemistry, nanotechnology, synthetic and chemical biology, biomaterials and materials science, and chemical engineering.
- There will also be an emphasis on front matter –commentaries, perspectives, mini-reviews, etc. – that will aid in disseminating the best of ACS Central Science research to an even broader constituency.
- It will highlight chemistry as the “central science” and seek to feature work at the interface with other scientific disciplines.
- The Journal of the American Chemical Society (JACS) is the flagship journal of the ACS, publishing about 3,000 scientific articles a year across a wide range of chemistry disciplines. ACS Central Science will publish 100-200 articles annually in its early years, and will be purely open access.
Q: Why was the journal named “Central Science”?
A: Chemistry is often referred to as “the central science.” ACS Central Science encourages submissions from researchers in wide array of disciplines reflecting the breadth of chemistry, chemical engineering, life sciences, and physical sciences.
Q: How will peer review be handled for ACS Central Science?
A: The journal will employ high standards of peer review, rapid times to decision and publication, and rigorous editorial processes as exemplified by the Society’s publishing program.
Q: How many papers will the journal publish in the first year?
A: Because ACS Central Science will be a highly selective journal, it will publish 100-200 articles annually in its early years. This journal seeks quality, not quantity of research. It will be free to both readers and authors, with sponsorship from the ACS. It will expand as warranted by high-quality submissions from authors and as additional sponsorship support allows.
Q: Are there any subscription fees to access content?
A: No. All articles will be freely available immediately upon publication.
Q: Are there any author charges to publish in the journal?
A: No. There are no author charges for publishing open access in this journal. Authors who wish/are required to publish under the terms of a Creative Commons license may elect to do so for a fee ($500 for ACS Members and $1000 for non-members in 2014).
Q: When will ACS Central Science begin accepting manuscripts and when will the journal begin publishing articles?
A: The journal will begin accepting manuscripts in 2014 following the Editor selection, refinement of the journal scope to reflect the Editor’s vision, and establishment of author guidelines. More specific dates will be shared at www.acsopenaccess.org as available.
Q: What are the licensing terms for this journal and can authors elect to use a CC-BY license?
A: There will be no publishing or subscription fees for the journal, but all other author rights and licensing for ACS Central Science will be consistent with that of other ACS Journals; i.e. there is no change from standard ACS AuthorChoice terms. ACS Central Science authors wishing to upgrade to a Creative Commons CC-BY license can do so by paying a fee ($500 for ACS Members and $1000 for non-members in 2014).
Q: Will articles from ACS Central Science always be free, regardless of the publication date?
A: Yes. As the Society’s first completely open access journal, all content will remain available free of access/subscription fees.
Q: What is ACS Editors’ Choice?
A: ACS Editors’ Choice is a new service designed to feature scientific articles of broad public interest and to make this material widely accessible to both the scholarly community and general public. The service started January 2014. ACS selects, features, and makes openly available one article per day to highlight an author’s newly published work.
Q: Is ACS Editors’ Choice a new or virtual journal?
A: It is not a new journal. ACS Editors’ Choice is a service for authors and readers aimed at maximizing the accessibility of work that exemplifies the Society’s commitment to improving people’s lives though the transforming power of chemistry.
Q: What article types are selected for ACS Editors’ Choice? Are they new or from earlier editions of ACS journals?
A: All peer-reviewed article types published in ACS journals are considered for selection in ACS Editors’ Choice. Articles are nominated into the ACS Editors’ Choice program at the time of original publication. However, in certain circumstances, ACS may elect to add articles published earlier into the ACS Editors’ Choice program based on renewed topical or scientific interest.
Q: How are articles in ACS Editors’ Choice open access?
A: Articles featured in the ACS Editors’ Choice program are open access immediately upon first posting on the web and remain open for all to access and read. There will be no access charges or article publishing charges for ACS Editors’ Choice.
Q: How are articles selected for ACS Editors’ Choice?
A: Articles selected are based on recommendations from the more than 400 Editors of ACS’s 44 peer-reviewed journals who are active researchers located around the world. A panel of ACS Publications Managing Editors, each PhD-level scientists conversant with the current scientific research, select articles for inclusion.
Q: Are the author publishing agreements and licensing arrangements for this new service the same as with ACS journals?
A: Yes. Authors sign the ACS’s standard Journal Publishing Agreement upon submission. Once an article has been selected for ACS Editors’ Choice, authors are extended a complimentary ACS AuthorChoice publishing license for no fee. ACS author agreements may be found on the ACS Publications website’s Author and Reviewer Center.
Q: If an author chooses to make an article openly available by selecting one of the ACS AuthorChoice options, are they still eligible to be selected for ACS Editors’ Choice?
A: Yes, when an author has elected ACS AuthorChoice and his/her article is selected for ACS Editors’ Choice, ACS rebates or credits any ACS AuthorChoice fee already paid.
Q: What is ACS Author Rewards?
A: ACS Author Rewards is a direct-to-author open access stimulus program. Each article published in ACS journals during 2014 qualifies the published corresponding author for ACS Author Rewards credit. Credits issued under this program, two $750 credits for a total value of $1,500 per publication, may be used to offset article publishing charges and any ACS open access publishing services of the author’s choosing, and will be redeemable over the next three years (2015—2017).
Q: Why is ACS offering this program?
A: ACS recognizes that research communities may require time to fund and transition to new open access publishing models and for this reason is sponsoring a direct-to-author open access stimulus program, ACS Author Rewards.
Q: When will credits become available? When can they be used? Can they be used to convert articles previously published by ACS into open access ACS AuthorChoice?
A: All peer-reviewed articles published in ACS journals in 2014 are eligible for ACS Author Rewards. ACS anticipates issuing credits in the latter half of 2014, and they will be deposited in authors’ ACS ChemWorx accounts (if you don’t have an account, sign up at www.acschemworx.org – it’s free!). ACS Author Rewards can be used to fund any ACS AuthorChoice option for newly or previously published peer-reviewed article. ACS Author Rewards can be redeemed between January 1, 2015, and December 31, 2017.
- Authors may use ACS Author Rewards credits to retroactively fund any ACS AuthorChoice option for articles published in ACS journals earlier than 2015.
- ACS Author Rewards credits are applied to the net price of an ACS AuthorChoice invoice, i.e. after additional discounts for Membership of Subscription status are applied.
Q: Is there a limit on the number of vouchers that can be earned?
A: There is no limit on the number of vouchers an author can earn. Please note, however, that vouchers are only being issued to published corresponding authors of peer-reviewed articles published in ACS journals in 2014.
Q: Are credits transferable to another author?
A: Yes, the published corresponding author may transfer credits to any other colleague to apply toward any ACS AuthorChoice option during 2015-2017.
Q: Can credits be redeemed for cash, products, services, or ACS membership?
A: No. Credits can only be used for ACS AuthorChoice options from January 1, 2015, to December 31, 2017. ACS Author Reward credits have no monetary value.
Q: Can a credit voucher be split?
A: ACS Author Rewards will be issued as 2 credits, each worth $750 for a total value of $1,500 per article published in 2014. They will be redeemable for open access publishing services from ACS. The two $750 credits can be:
- Used individually on 2 separate articles published Open Access.
- Combined to purchase full or partial credit to any ACS AuthorChoice option, including Creative Commons licenses.
- Given by the published corresponding author to another colleague.
- All rewards must be redeemed by December 31, 2017.
Please note, however, an individual $750 credit cannot be split, no “change” can be given to the author for the purchase of services less than the credit’s full value.
Q: Can previously published articles be purchased with ACS Author Rewards credits?
A: Yes, authors may use ACS Author Rewards program to convert articles published earlier than 2014 in ACS journals to open access. Please note that ACS Author Rewards credits will only be issued to the published corresponding authors of peer-reviewed articles published in ACS journals in 2014.
Q: If there are five authors of an article, do they all get the ACS Author Rewards credit or just primary authors?
A: Only the published corresponding author(s) receives the ACS Author Rewards credits. It’s a total of $1,500 in credits per published article; at the published corresponding author’s own choosing, the credits may be given to one or more co-authors or other colleagues (see above).
Q: What is ACS AuthorChoice?
A: ACS AuthorChoice an easy and cost-effective route to open access for authors who publish in ACS journals. This program facilitates immediate unrestricted Web access to the published article (the version of record) for a one-time fixed payment provided by the author or the author’s funding agency.
Since January 2014, authors or their funding sponsors who elect this fee-based option are able to select from an expanded menu of licensing options to make the final published article openly available to readers worldwide, both from the ACS website and other repositories of the author’s choosing. ACS AuthorChoice has been updated to allow authors to choose between immediate or 12-month open access of the final published article.
ACS AuthorChoice options provide additional discounts to authors that are:
- Members of the American Chemical Society, and/or
- Are affiliated with academic institutions that subscribe to the ACS All Publications program.
Under either ACS AuthorChoice “immediate availability” or “availability after 12 months” options, authors have three fee-based options:
- Publish under the terms of the standard ACS AuthorChoice license
- Publish under the terms of a Creative Commons Attribution Noncommercial No Derivative Works (CC-BY-NC-ND) license
- Publish under the terms of a Creative Commons Attribution (CC-BY) license
Note that an additional service fee applies to the use of a Creative Commons license.
Q: What is the ACS AuthorChoice option for “availability after 12 months,” now branded as ACS AuthorChoice+12?
A: This option converts the article to open availability 12 months after the article’s original publication date, consistent with many funders’ or institutional open access guidelines. However, please note, consistent with NIH requirements, articles published under ACS AuthorChoice+12 will still be deposited with the funder’s repository at time of publication.
Q: I have been told I need to deposit my work in a funder or institutional repository. What are my options with ACS?
A: ACS published authors have the following options:
- ACS authors required by funder or institutional mandate to deposit their work may deposit the accepted manuscript for open access 12 months after original publication. (They may deposit sooner, as long as they make the repository aware of embargo restrictions.) There is no fee or additional license required.
- Authors wishing/required to deposit the final published article in a repository may elect ACS AuthorChoice or ACS AuthorChoice+12 and ACS will automatically deposit the final published article in a repository specified by the author.
- ACS will also provide authors with a digital copy for self-archiving on their website or other locations.
- With the ACS Certified Deposit program, ACS will maintain long-term records verifying compliance with the author’s deposit requirements.
- If the author wishes/is required to adhere to a Creative Commons License (CC-BY), the author may purchase an add-on Creative Commons license to supplement ACS AuthorChoice.
Q: Does ACS AuthorChoice offer assistance with open access manuscript deposit requirements of their employers or funders?
A: ACS authors may deposit the accepted manuscript with a funder/institutional repository 12 months after original publication at no charge. Authors who participate in ACS AuthorChoice, or other ACS open access initiatives, may elect to have ACS automatically deposit the final published article to appropriate agencies and archives, and ACS will maintain records to document compliance with the relevant open access policy requirements. ACS Publications offers this author service as part of its emphasis on the stewardship of the integrity of the scientific record.
Q: What is the difference between the final published article and the accepted manuscript version of an article?
A: The accepted manuscript is the post-peer review draft, accepted by the journal, prior to additional editing and production enhancement by ACS Publications. The final published article is the professionally edited, enhanced, and typeset version of the article, as it appeared in publication in the journal, in either PDF or HTML format.
Q: Does ACS provide any special assistance for authors with NIH funder requirements?
A: Yes, ACS is revising its offering to authors whose research is funded by NIH during 2014. Starting March 4, 2014 and throughout the calendar year 2014, ACS is providing authors funded by NIH who acknowledge this funding in published 2014 articles with a complimentary ACS AuthorChoice+12 license for that article.
- ACS AuthorChoice+12 provides embargoed (after 12 months) open availability of the final published article on the ACS Publications website.
- ACS AuthorChoice + 12 also provides Certified Deposit, where ACS will automatically and immediately deposit the final published article on the author’s behalf, the version of record, into the PMC with a 12-month embargo.
- ACS is implementing this complimentary upgrade in recognition of 2014 being a transition year, both for ACS as we establish our systems and processes for an open access economy and for the scientific community as funding and mandates continue to evolve. Additionally, we recognize authors whose research is funded by NIH must decide at the time of publication whether they will deposit the accepted manuscript or have the Publisher deposit the final published article, the version of record.
Q: Do NIH-funded authors also receive ACS Author Rewards credits?
A: Yes, NIH-funded authors of published 2014 articles also receive ACS Author Rewards credits. For articles published in ACS journals in 2014, the published corresponding author receives two credits, each worth $750, for a total value of $1,500 per article. These credits can be used to offset the costs of any ACS open access option between January 1, 2015, and December 31, 2017. ACS Author Rewards credits will be accessible via authors’ ACS ChemWorx account before the end of 2014. (Sign up for free access at www.acschemworx.org.)
Q: Does this revised offering for NIH-funded authors change after 2014?
A: Yes, all NIH-funded authors who publish with ACS during 2014 will be notified that, starting January 1, 2015, ACS will deposit content only when that content is purchased through the ACS AuthorChoice program, with funds they provide or with an ACS Author Reward earned. We believe that moving this policy back one year allows NIH funded authors more time to consider and prepare for this change, to understand how they will handle funding, and importantly—we note that those who have published during 2014 with ACS will have access to ACS Author Rewards credits before January 1, 2015, they can use to offset costs of open access options. This approach is in keeping with the ACS commitment to uphold the integrity of the version of record that is the final published article. Authors who do not wish to sponsor ACS AuthorChoice may still comply with NIH mandates by deposting the accepted manuscript themselves, under a 12-month post-publication embargo, at no charge.
Q: What are the fees associated with the expanded ACS AuthorChoice options?
A: ACS AuthorChoice options are available for as low as $750 to qualifying authors, and is free to authors selected for either the ACS Editors’ Choice service or for original publication in ACS Central Science.
- To view a PDF chart of options and pricing, go to the ACS AuthorChoice page on the ACS Open Access website (www.acsopenaccess.org).
Q: Will the terms and conditions of the ACS AuthorChoice license change with the expanded options?
A: No. The terms of ACS AuthorChoice options will not change. The only new difference is a new option (ACS AuthorChoice+12) providing for open access availability at 12 months post publication. ACS is offering that as a lower cost option for authors who wish or need to sponsor open access of the final published article in 12 months and who want to benefit from other services or licensing options associated with the ACS AuthorChoice program.
Q: Are institutions or funders allowed to purchase ACS AuthorChoice?
A: Payments of ACS AuthorChoice fees are accepted from authors regardless of where those funds originate, e.g. funder or institutional grants. Institutions and funders may directly pay ACS AuthorChoice fees under separate arrangement with ACS.